SMS Lifesciences India Ltd

SMS Lifesciences India Ltd Share Price Today: Live Updates & Key Insights

Get insights on SMS Lifesciences India Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

SMS Lifesciences India Ltd Share Price Chart

SMS Lifesciences India Ltd Fundamentals

Traded Volume: 441

Market Cap(Cr): 354

Avg Traded Price 641.93

1 Year return -15.77%

Upper Circuit 1,184.9

Lower Circuit 1,144.9

P/E TTM 21.00

P/B Ratio 57.00

Traded Value(Cr) 5.16

EPS TTM 57.116

Book value 57.116

Dividend 0.00%

SMS Lifesciences India Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights SMS Lifesciences India Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the SMS Lifesciences India Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +0.62%

1M +1.27%

3M +0.80%

1Y -15.77%

YTD -4.07%

SMS Lifesciences India Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights SMS Lifesciences India Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 502.00

Day Before Yesterday 388.00

1W Avg 1042.25

1M Avg 745.95

3M Avg 1137.59

SMS Lifesciences India Ltd Technical Details

SMS Lifesciences India Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 1149

Support 2 1127

Support 3 1109

Pivot Point : 1167

Resistance 1 1189

Resistance 2 1207

Resistance 3 1229

SMS Lifesciences India Ltd Corporate Actions

SMS Lifesciences India Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on SMS Lifesciences India Ltd’s capital allocation strategies.

All

Ex-Date 24-Sep-2025 Type D Description 1.50/share@15.00% Record Date 24-Sep-2025 Ratio 15.00

Ex-Date 23-Sep-2024 Type D Description 1.50/share@15.00% Record Date 23-Sep-2024 Ratio 15.00

Ex-Date 22-Sep-2023 Type D Description 1.50/share@15.00% Record Date 07-Nov-2025 Ratio 15.00

Ex-Date 22-Sep-2022 Type D Description 1.50/share@15.00% Record Date 07-Nov-2025 Ratio 15.00

Ex-Date 20-Sep-2021 Type D Description 1.50/share@15.00% Record Date 21-Sep-2021 Ratio 15.00

Ex-Date 19-Sep-2019 Type D Description 1.50/share@15.00% Record Date 07-Nov-2025 Ratio 15.00

Dividends

Announcement Date 24-Sep-2025 Ex Dividend Date 24-Sep-2025 Dividend(%) 15

Announcement Date 23-Sep-2024 Ex Dividend Date 23-Sep-2024 Dividend(%) 15

Announcement Date 22-Sep-2023 Ex Dividend Date 22-Sep-2023 Dividend(%) 15

Announcement Date 22-Sep-2022 Ex Dividend Date 22-Sep-2022 Dividend(%) 15

Announcement Date 20-Sep-2021 Ex Dividend Date 20-Sep-2021 Dividend(%) 15

Announcement Date 19-Sep-2019 Ex Dividend Date 19-Sep-2019 Dividend(%) 15

Bonus

No Bonus has been declared by SMSLIFE

Splits

No Split has been declared by SMSLIFE

Others

Rights No Rights has been declared by SMSLIFE

SMS Lifesciences India Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares SMS Lifesciences India Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate SMS Lifesciences India Ltd's relative performance and valuation against major competitors.

Stock Name Everest Organics Ltd ₹410.05 (+3.16%) M. Cap (Cr) 3.98 1 Yr Return (%) +223.77% P/E (TTM) 64.17 PB Ratio 9.42

Stock Name Infinium Pharmachem Ltd ₹264.90 (-0.04%) M. Cap (Cr) 4.13 1 Yr Return (%) -20.84% P/E (TTM) 45.26 PB Ratio 5.83

Stock Name Trident Lifeline Ltd ₹308.00 (+0.67%) M. Cap (Cr) 3.57 1 Yr Return (%) -2.22% P/E (TTM) 33.47 PB Ratio 6.10

Stock Name SMS Lifesciences India Ltd ₹1171.00 (+1.76%) M. Cap (Cr) 3.54 1 Yr Return (%) -15.77% P/E (TTM) 20.50 PB Ratio 1.89

Stock Name Gennex Laboratories Ltd ₹14.26 (-0.35%) M. Cap (Cr) 3.24 1 Yr Return (%) -34.07% P/E (TTM) 19.73 PB Ratio 1.90

Stock Name Zim Laboratories Ltd ₹71.03 (+0.30%) M. Cap (Cr) 3.46 1 Yr Return (%) -38.86% P/E (TTM) 36.84 PB Ratio 1.37

Stock Name Lyka Labs Ltd ₹94.07 (+0.50%) M. Cap (Cr) 3.36 1 Yr Return (%) -37.24% P/E (TTM) 44.71 PB Ratio 3.39

SMS Lifesciences India Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by SMS Lifesciences India Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 28.03 Mar 2024 14.75 Mar 2023 4.58 Mar 2022 -14.66 Mar 2021 21.62

PARTICULARS Investing Activities Mar 2025 -13.77 Mar 2024 -13.75 Mar 2023 -27.96 Mar 2022 -7.49 Mar 2021 -5.94

PARTICULARS Financing Activities Mar 2025 -14.20 Mar 2024 -0.82 Mar 2023 22.59 Mar 2022 14.63 Mar 2021 -7.87

PARTICULARS Net Cash Flow Mar 2025 0.07 Mar 2024 0.18 Mar 2023 -0.80 Mar 2022 -7.52 Mar 2021 7.81

SMS Lifesciences India Ltd Shareholding Pattern

This shows the ownership breakdown of SMS Lifesciences India Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 71.41%

Public 28.57%

Other Institutions 0.03%

FII null%

Mutual Funds null%

About SMS Lifesciences India Ltd

SMS Lifesciences India Limited was incorporated originally as Potluri Real Estate Private Limited on May 31, 2006. The Company's name was changed to Potluri Packaging Industries Private Limited on 6 November, 2013 and again changed to SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016.The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates. The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments. SMS Group was given the export house status in the year 1997-98.Having three multi product facilities in operation and a research centre, the Company executed contract manufacturing and research assignment for global customer base. The Scheme of Arrangement between SMS Pharmaceuticals Limited with the Company was implemented in 2016-17. Pursuant to the Scheme, the Semi Regulated facilities i.e Unit No. I, IV and V along with premises situated at Industrial Estate, Sanathnagar, Hyderabad; Industrial Development Area, Jeedimetla, Hyderabad; Premises bearing Flat No.417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad; vacant land admeasuring Ac 19.00 cents situated at Pharma City, Parawada, Visakhapatnam and Investments relating to Semi Regulated Units of SMS Pharmaceuticals Limited got demerged into the Company and the said Scheme of Demerger was given effect on May 17, 2017. The Company allotted 30,23,287 Equity Shares of Rs. 10 each to the shareholders of SMS Pharmaceuticals Limited on 27 June, 2017 in pursuance of Demerger Scheme.The Company made Mahi Drugs Private Limited as a wholly owned subsidiary of the Company in 2017-18. by acquiring 9,00,000 Equity Shares effective on 17th September, 2018. Similarly, the Company diluted its 10% stake in Mahi Drugs Private Limited during the period 2021-22 and it ceased to be a wholly-owned subsidiary of the Company w.e.f. 7th February, 2022.Company completed two regulatory inspections by the US Food and Drug Administration (USFDA). Company's Unit 1 at Kazipally, Hyderabad underwent USFDA inspection in May, 2025, resulting in a successful outcome with a Voluntary Action Indicated (VAI) status. Additionally, the Company's subsidiary, Mahi Drugs also successfully completed its USFDA inspection in February, 2025 of its manufacturing facility located in Vizag, Andhra Pradesh. Company expanded the new API production line, which is expected to become operational in the latter half of the year 2025-26.

Managing Director

T V V S N Murthy

Registered office Plot No 19-III Road No 71, Opp Bharatiya Vidya Bhavan PSc, Hyderabad, Telangana, 500096

FAX :91-040-6628-8888

Background

Incorporation Year 2006

Face Value ₹10.00

Market Lot 1

SMS Lifesciences India Ltd Latest News

VIEW MORE NEWS

FAQs on SMS Lifesciences India Ltd